Skip navigation

DSpace

機構典藏 DSpace 系統致力於保存各式數位資料(如:文字、圖片、PDF)並使其易於取用。

點此認識 DSpace
DSpace logo
English
中文
  • 瀏覽論文
    • 校院系所
    • 出版年
    • 作者
    • 標題
    • 關鍵字
    • 指導教授
  • 搜尋 TDR
  • 授權 Q&A
    • 我的頁面
    • 接受 E-mail 通知
    • 編輯個人資料
  1. NTU Theses and Dissertations Repository
  2. 醫學院
  3. 微生物學科所
請用此 Handle URI 來引用此文件: http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/20490
完整後設資料紀錄
DC 欄位值語言
dc.contributor.advisor孫錦虹
dc.contributor.authorZi-Qi Linen
dc.contributor.author林子琦zh_TW
dc.date.accessioned2021-06-08T02:50:32Z-
dc.date.copyright2017-09-13
dc.date.issued2017
dc.date.submitted2017-08-16
dc.identifier.citation1. Lane S, Lloyd D. Current trends in research into the waterborne parasite Giardia. Crit Rev Microbiol 2002
2. O'Handley RM, Buret AG, McAllister TA, Jelinski M, Olson ME. Giardiasis in dairy calves: effects of fenbendazole treatment on intestinal structure and function. Int J Parasitol 2001; 31(1): 73-9.
3. .Svard SG, Hagblom P, Palm JE. Giardia lamblia -- a model organism for eukaryotic cell differentiation. FEMS Microbiol Lett 2003; 218(1): 3-7.
4. Adam RD. Biology of Giardia lamblia. Clin Microbiol Rev 2001; 14(3): 447-75.
5. Bernander R, Palm JE, Svärd SG. Genome ploidy in different stages of the Giardia lamblia life cycle. Cell Microbiol 2001; 3(1): 55-62.
6. Rendtorff RC. The experimental transmission of human intestinal protozoan parasites. II. Giardia lamblia cysts given in capsules. Am J Hyg 1954; 59(2): 209-20.
7. Farthing MJ. The molecular pathogenesis of giardiasis. J Pediatr Gastroenterol Nutr 1997; 24(1): 79-88.
8. Buret AG. Mechanisms of epithelial dysfunction in giardiasis. Gut 2007; 56(3): 316-7.
9. Ankarklev J, Jerlström-Hultqvist J, Ringqvist E, Troell K, Svärd SG. Behind the smile: cell biology and disease mechanisms of Giardia species. Nat Rev Microbiol 2010; 8(6): 413-22.
10. Tejman-Yarden N, Eckmann L. New approaches to the treatment of giardiasis. Curr Opin Infect Dis 2011; 24(5): 451-6.
11. Gottig N, Elias EV, Quiroga R, Nores MJ, Solari AJ, Touz MC et al. Active and passive mechanisms drive secretory granule biogenesis during differentiation of the intestinal parasite Giardia lamblia. The Journal of biological chemistry 2006; 281(26): 18156-66.
12. Lauwaet T, Davids BJ, Reiner DS, Gillin FD. Encystation of Giardia lamblia: a model for other parasites. Curr Opin Microbiol 2007; 10(6): 554-9.
13. Bittencourt-Silvestre J, Lemgruber L, de Souza W. Encystation process of Giardia lamblia: morphological and regulatory aspects. Arch Microbiol 2010; 192(4): 259-65.
14. Paget TA, Macechko PT, Jarroll EL. Metabolic changes in Giardia intestinalis during differentiation. J Parasitol 1998; 84(2): 222-6.
15. Wiedenheft, B., Sternberg, S.H. & Doudna, J.A. RNA-guided genetic silencing systems in bacteria and archaea. Nature 482, 331–338 (2012)
16. The new frontier of genomeengineering with CRISPR-Cas9 Jennifer A. Doudna* and Emmanuelle Charpentier* Corrected 25 November, 2014; see full text
17. Engineered CRISPR-Cas9 nucleases with altered PAM specificities. Kleinstiver BP, Prew MS, Tsai SQ, Topkar VV, Nguyen NT, Zheng Z, Gonzales AP, Li Z, Peterson RT, Yeh JR, Aryee MJ, Joung JK. Nature. 2015 Jul 23;523(7561)
18. Jiang, W., Bikard, D., Cox, D., Zhang, F. & Marraffini, L.A. RNA-guided editing of bacterial genomes using CRISPR-Cas systems. Nat. Biotechnol. 31, 233–239 (2013).
19. Sander, J.D. & Joung, J.K. CRISPR-Cas systems for editing, regulating and targeting genomes. Nat. Biotechnol. 32, 347–355 (2014).
20. Yang, H. et al. One-step generation of mice carrying reporter and conditional alleles by CRISPR/Cas-mediated genome engineering. Cell 154, 1370–1379 (2013).
21. Wang, H. et al. One-step generation of mice carrying mutations in multiple genes by CRISPR/Cas-mediated genome engineering. Cell 153, 910–918 (2013).
22. Mali, P. et al. RNA-guided human genome engineering via Cas9. Science 339, 823–826(2013).
23. Panier, S. & Boulton, S.J. Double-strand break repair: 53BP1 comes into focus. Nat. Rev. Mol. Cell Biol. 15, 7–18 (2014).
24. Boboila, C. et al. Alternative end-joining catalyzes class switch recombination in the absence of both Ku70 and DNA ligase 4
25. Biochemical kinetics model of DSB repair and induction of gamma-H2AX foci by non-homologous
end joining.
26. Efficient genome engineering of Toxoplasma gondii using CRISPR/Cas9. Sidik SM, Hackett CG1, Tran F2, Westwood NJ2, Lourido S1. PLoS One. 2014 doi: 10.1128/mBio.01114-14 13 May 2014 mBio vol. 5 no. 3 e01114-14
27. An Inhibitor of Nonhomologous End-Joining Abrogates Double-Strand Break Repair and Impedes Cancer Progression Volume 151, Issue 7, 21 December 2012, Pages 1474–1487
28. Regulation of Cyst Wall Protein Promoters by Myb2 in Giardia lamblia Received for publication, July 2, 2008,
29. Functional Redundancy of Two Pax-Like Proteins in Transcriptional Activation of Cyst Wall Protein Genes in Giardia lamblia
30. Regulation of a Myb Transcription Factor by Cyclin-dependent Kinase 2 in Giardia lamblia Received for publication, August 29, 2011, and in revised form, December 12, 2011 Published, JBC Papers in Press, December 13, 2011, DOI 10.1074/jbc.M111.298893
31. CRISPR technologies for bacterial systems: Current achievements and future directions. 2016 Nov 15;34(7):1180-1209. doi: 10.1016/j.biotechadv.2016.08.002. Epub 2016 Aug 24.
32. CRISPR/Cas9 mediated sequential editing of genes critical for ookinete motility in Plasmodium yoelii. Mol Biochem Parasitol. 2017 Mar;212:1-8. doi: 10.1016/j.molbiopara.2016.12.010. Epub 2016 Dec 26.
33. Inhibition of nonhomologous end joining to increase the specificity of CRISPR/Cas9 genome editing. FEBS J. 2015 Nov;282(22):4289-94. doi: 10.1111/febs.13416. Epub 2015 Sep 9.
34. Neomycin and puromycin affect gene expression in Giardia lamblia stable transfection. Mol Biochem Parasitol. 2007 Dec;156(2):124-35. Epub 2007 Jul 31.
35. Cyst-Wall-Protein-1 is fundamental for Golgi-like organelle neogenesis and cyst-wall biosynthesis in Giardia lamblia.Ebneter JA, Heusser SD, Schraner EM, Hehl AB, Faso C.Nat Commun. 2016 Dec 15;7:13859.
36. Stable DNA transfection of the primitive protozoan pathogen Giardia lamblia Chin-Hung Sun,Chun-Fen Chou, Jung-Hsiang Tai Molecular and Biochemical Parasitology 92 (1998) 123–132
dc.identifier.urihttp://tdr.lib.ntu.edu.tw/jspui/handle/123456789/20490-
dc.description.abstract梨形鞭毛蟲(Giardia lamblia)是全球性之致病性的腸內原蟲寄生蟲,感染途徑是透過飲用受汙染之水源。滋養體寄生於小腸,隨著腸內環境改變會進行囊體化作用(encystation),形成具有囊壁之感染型 ── 囊體(cyst)。囊壁是梨形鞭毛蟲的構造,能夠抵禦惡劣環境下生存所需,其主要由多醣類還有蛋白質所構成。梨形鞭毛蟲的生活史分成兩種型態,一種為擁有兩個核並具有鞭毛運動性之滋養體(trophozoite),另一種是四個核的成熟囊體。在囊體化階段中,囊體蛋白質(cyst wall protein, cwp)的表現量會大量增加。
近年來,基因组编輯技術(genome editing technology)透過特定的核酸酶在DNA上進行剪切。基因剪切後進一步透過兩種方式來達到修復動作,一則是非同源末端接合機制(non-homologous end joining, NHEJ)來修復DNA斷裂的切位,另一則是利用同源重组機制(homologous recombination)針對斷點附近的基因序列進行同源序列修復(homology direct repair,HDR),而達到基因置換的結果。Cas9蛋白質會辨識入侵病毒或是外來質體上的Protospacer adjacent motif (PAM),並且切割緊鄰的雙股genomic DNA區間,造成genomic DNA形成雙股斷裂,隨後進行基因修復。
過去沒有實驗室建立梨形鞭毛蟲的CRISPR/Cas9系統,本研究將建立一套梨形鞭毛蟲的CRISPR/Cas9系統,以利未來可以研究基因相關功能。針對myeloid leukemia factor (MLF) protein (orf 16424)基因來設計基因剔除系統。本實驗室發現MLF已知會出現在囊泡中,MLF大量表現時,梨形鞭毛蟲的囊壁蛋白質cwp1表現量會增加。將含有所需序列之DNA“修復模板’’、guide RNA和Cas9的質體透過轉染輸送到細胞內。DNA“修復模板’’內含有置換目標基因MLF基因上,下游基因序列和Puromycin resistance (Puromycin N-acetyltransferase, pac) gene,透過Cas9 蛋白質會誘導DNA斷裂,當細胞若進行HDR修復,就會將所設計好的質體和genomic DNA置換,使得細胞含有抗藥性基因。利用加入Puromycin來篩選具抗藥性的細胞,可成功篩選出行使HDR的細胞。利用PCR將基因放大做定序,也成功確認梨形鞭毛蟲MLF基因有部分成功被置換掉。本實驗也為了釐清MLF基因基因被置換掉的比率,透過即時定量聚合酶鍊式反應(quantitative PCR;qPCR)偵測genomic DNA置換比率。可以觀察到genomic DNA上的目標基因MLF部分剔除。在MLF部分基因剔除下,觀察相關蛋白質表現量和RNA表現量,可以發現成功剔除MLF部分genomic DNA下,MLF的RNA和蛋白質的量值也下降。透過螢光顯微鏡觀察型態方式觀察MLF囊泡數目量值下降,而MLF的調控目標-囊壁蛋白質cwp1蛋白質和RNA量值也下降。所形成的囊壁有變薄的趨勢。囊體計數下,可以觀察到形成的囊體數目也有下降。透過諸多證明CRISPR/Cas9系統是可以成功置換掉梨形鞭毛蟲的genomic DNA,也發現MLF對於cwp1有正調控。本實驗也將藥物去除,使得細胞質體脫落,來觀察失去藥篩選還有失去質體下的細胞和對照組的差別,結果和用藥物篩選時的表現量趨勢相同。
根據過去文獻,已知細胞在DSB (double strand break) 情況下,利用HDR修復的效率通常較低,即便是在表達Cas9、guide RNA和外源性修復模板細胞。由於Cas9蛋白質誘導DNA斷裂的效率相對較高和HDR的低效率,會促使細胞較會透過NHEJ的機制來修復。因此,本研究還透過NHEJ抑制劑─SCR7,會在修復時期抑制DSB的連接,並且阻止連接酶IV接合在DSB的DNA上,而導致在細胞內的DNA雙鏈斷裂的累積。SCR7還會抑制細胞內的NHEJ對連接酶IV依賴性,隨之激活內在凋亡途徑,提高HDR效能。故本實驗在轉染後24小時加入SCR7,用來抑制NHEJ參於修復機制的比率,提高HDR的效率。結果發現可以獲得較高的置換效能,相較於未使用SCR7的組別,MLF基因剔除比率提高,MLF的RNA和蛋白質的量值也下降。而MLF的調控目標-囊壁蛋白質cwp1蛋白質和RNA量值也下降。
另外也建立另一個CRISPR/Cas9系統,是利用neomycin來篩選出成功MLF基因,結果發現可成功剔除MLF部分genomic DNA下,MLF的RNA和蛋白質的量值也下降。而MLF的調控目標-囊壁蛋白質cwp1蛋白質和RNA量值也下降。囊體計數下,可以觀察到形成的囊體數目也有下降。本實驗也將成功基因置換成功的細胞株去藥後,去比對WB細胞株的相關基因、蛋白質的表現,也能夠再次確認細胞株有成功個別剔除myeloid leukemia factor (MLF) protein (orf 16424)基因。另外,還改變了DNA修復模板的形式為雙股模板,還有透過另一種方式將DNA“修復模板’’、guide RNA和Cas9整合在一條質體的方式,結果也是可以成功剔除MLF部分genomic DNA。結論是利用DNA修復模板的形式為雙股模板,是可以使質體脫去的效率提升,降低時間,可以比較和野生株的表現量。若是形成持續表現質體的單一質體的方式可以使質體一直持續性的表現Cas9、guide RNA和修復模板。也實驗利用neomycin來篩選出成功的細胞在轉染帶有MLF表現的質體,觀察MLF表現量也都有上升的趨勢。
由於CRISPR/Cas9系統建立,但不知是否對於其他基因也有效能。所以也針對HTH domain(orf2732)的基因做相同的設計,也發現可以達到部分剔除HTH domain基因,也可以發現當HTH domain基因目標基因部分剔除時,HTH domain的RNA和蛋白質的量值也下降。而HTH domain的調控目標-囊壁蛋白質cwp1蛋白質和RNA量值也下降。形成的囊壁也有變薄的趨勢。故透過此系統也可以剔除部分HTH domain基因。透過這個系統的建立,以利後面對於梨形鞭毛蟲的基因分析有極大的幫助。
zh_TW
dc.description.abstractGiardia lamblia is one of the most common protozoan parasites causing waterborne intestinal infections in humans. Cyst surives in hostile environment. G. lamblia have two stages in the life cycle: a flagellated trophozoite with 2 nuclei and an inert cyst with 4 nuclei. During encystation, differentiation from a trophozoite into a cyst, the cyst wall protein (CWPs) is highly synthesized in a concerted manner.
Precise genome-editing relies on the repair of sequence-specific nuclease-induced DNA nicking or double-strand breaks (DSBs) by homology-directed repair (HDR) and (non-homologous end joining, NHEJ). The RNA guided enzyme Cas9, which originates from the CRISPR-Cas adaptive bacterial immune system, is transforming biology by providing a genome engineering tool. Recently, the CRISPR/Cas9 system was adapted for targeted genome editing in a variety of organisms. The Cas9 enzyme generates breaks in double-stranded DNA by using its two catalytic centers to cleave each strand of a DNA target site next to a Protospacer adjacent motif (PAM) sequence. After double-stranded DNA breaks are generated, DNA repair occurs .
In this research, we developed a CRISPR / Cas9 system to remove the myeloid leukemia factor (MLF) protein (orf 16424) gene in G. lamblia. MLF has been found to induce cwp1 expression. We transfected the plasmid consisting of DNA 'repair template',guide RNA, Cas9 into the cells. The DNA 'repair template' contains upstream and downstream of MLF gene sequences with puromycin resistance gene, puromycin N-acetyl-transferase (pac). The cas9 gene product can induce DNA breaks. If the cells perform the repair action of HDR, the designed repair template will replace Giardia lamblia genomic DNA and make the cells contain drug-resistant genes.We used puromycin to select the drug resistant cells. We also used PCR to amplify the genes for sequencing and successfully confirmed that the MLF gene was successfully replaced. In order to clarify the rate of MLF gene replacement, we detected the replacement ratio by quantitative PCR (qPCR).We also measured the amount of expression of the relevant proteins and RNA expression through Western blot, RT-PCR, quantitative RT-PCR (qRT-PCR) and cyst count. Through above experiments we confirmed the genome replacement. It was observed that the target gene MLF was partially excluded from genomic DNA. In the MLF gene exclusion, it can be found that in the MLF part of the genomic DNA, MLF RNA and protein values also decreased. The amount of MLF vesicles was decreased by fluorescence microscopy, while the amount of protein and RNA of cystic protein cwp1 was also decreased. The formation of the wall has a thinning trend. The number of cysts formed can also be observed to decrease. Through a number of proven CRISPR / Cas9 system is able to successfully replace the Giardia genomic DNA. Also we found that MLF can positively regulate cwp1 expression. In this study, the puromycin was also removed, leaving the plasmid off, to observe effect of the loss of drug selection and loss of plasmid.
According to the previous study, Cas9-mediated modification of the murine genome through NHEJ can reach efficiencies of 20–60%. But HDR has lower efficiency. Because NHEJ is error-prone and introduces unpredictable patterns of deletions, it is suitable for introducing small random mutations. HDR is less frequent than NHEJ and occurs only during S and G2 phase, whereas NHEJ occurs throughout the cell cycle. Scr7 targets the DNA binding domain of DNA ligase IV and reduces its affinity for DSBs and inhibiting its function. We used Scr7 to enhance the frequency of HDR by transiently blocking NHEJ, resulting in precise genome editing by CRISPR-Cas9. The MLF gene knockout ratio was increased, and the amount of MLF RNA and protein was also decreased compared to the group without the use of SCR7.
In addition, another CRISPR / Cas9 system was established, and neomycin was used to screen out the successful MLF gene. The results showed that the MLF RNA and protein were also decreased in the MLF genomic DNA. While the MLF and cwp1 protein and RNA values also decreased. The number of cyst formed can also be observed to decrease. We will also succeed in isolating myeloid leukemia factor (MLF) protein (orf 16424) by successively demonstrating that the cell lines have succeeded in isolating the genes and proteins of the WB cell line after successful drug replacement.
In addition, the DNA repair template has been changed in the form of a double strand template can remove target gene. Also the DNA 'repair template', guide RNA and Cas9 are integrated in a plasmid form can remove target gene. . The conclusion is that the use of DNA repair template in the form of a double strand template is the ability to make the removal of the plasmids to improve the efficiency, reduce the time, can be compared with the wild type of the amount of performance.If the formation of a single plastid can continue performance of Cas9, guide RNA and repair template. Also use of neomycin to screen out the success of cells in the transfection of MLF with the performance of the plasmids, observed MLF performance also increased.
Since the CRISPR / Cas9 system was established, it was not known whether it was effective for other genes. Therefore, the HTH domain gene (orf2732) is also designed for knock down experiment. It is also found that the HTH domain gene can be partially excluded. It can also be found that the amount of RNA and protein of HTH domain also decreases when the target gene of HTH domain gene is partially eliminated. And HTH domain regulation target cwp1 protein and RNA values also decreased. The formation of the wall also has a thinning trend. So through this system can also be removed part of the HTH domain gene. Through the establishment of this system, it is of great help facilitate the subsequent analysis of the genetic analysis of Giardia.
en
dc.description.provenanceMade available in DSpace on 2021-06-08T02:50:32Z (GMT). No. of bitstreams: 1
ntu-106-R04445205-1.pdf: 12501892 bytes, checksum: 9cd513bca6286d9d604f123992b49bfd (MD5)
Previous issue date: 2017
en
dc.description.tableofcontents目錄
口試委員會審定書 i
致謝 ii
中文摘要 iii
ABSTRACT vi
目錄 ix
圖目錄 xiii
表目錄 xiv
第一章 前言 (Introduction) 1
1.1梨形鞭毛蟲簡介 1
1.2梨形鞭毛蟲囊體化 1
1.3梨形鞭毛蟲缺乏knock out system 2
1.4 CRISPR/Cas9 System 2
1.5非同源末端接合機制(NHEJ) 2
1.6同源重组機制(HDR) 3
1.7研究動機 3
第二章 材料與方法(Materials and Methods) 5
2.1梨形鞭毛蟲滋養體時期以及囊體化時期之培養(Giardia lamblia culture) 5
2.2轉殖質體之建構(Plasmid construction) 5
2.2.1 5’Δ5N-pac 5
2.2.2 5’- pac -3 UM(mlf) 5
2.2.3 5’- neo -3 UM(mlf) 6
2.2.4 psk 5’- pac -3 UM(mlf) 6
2.2.5 cas9 5’- pac -3 UM(mlf) 6
2.2.6 5’- pac -3 UM(HTH) 7
2.2.7 質體的轉型 8
2.2.8 質體的萃取 8
2.2.9 雙股DNA的萃取 8
2.3梨形鞭毛蟲的轉染與選殖(Transfection and Selection) 8
2.4免疫螢光染色(Immunofluorescence assay;IFA) 9
2.5Imaris | 3D and 4D Real-Time Interactive Data Visualization 將以Leica TCS SP5 Spectral Confocal System 9
2.6西方墨點法與Coomassie blue染色(Weatern blot and Coomassie blue stain) 9
2.7反轉錄聚合酶鍊式反應(RT-PCR) 10
2.7.1 Genomic DNA萃取 10
2.7.2 RNA萃取及RT-PCR 12
2.8即時定量反轉錄聚合酶鍊式反應(quantitative RT-PCR;qRT-PCR) 13
2.9囊體計數(Cyst count) 15
2.10NHEJ抑制劑-SCR7加入 15
2.11雙股模板的轉染與選殖 16
第三章 實驗結果 17
3.1梨形鞭毛蟲MLF CRISPR/Cas9系統之設計 17
3.2建立MLF基因剔除之梨形鞭毛蟲細胞株 17
3.3確定MLF 部分剔除之梨形鞭毛蟲細胞株建立 17
3.4梨形鞭毛蟲MLF 部分剔除的細胞株的表現 18
3.5去除質體和藥物後之MLF部分剔除細胞株建立 18
3.6去除質體和藥物後之MLF部分剔除細胞株的表現 19
3.7增加MLF 剔除效率之梨形鞭毛蟲細胞株建立 20
3.8增加MLF剔除效率之梨形鞭毛蟲細胞株之建立 20
3.9增加MLF剔除效率之梨形鞭毛蟲細胞株之表現 20
3.10比較有無Scr7之MLF剔除效率 21
3.11 透過G418篩選建立MLF 剔除之梨形鞭毛蟲細胞株 22
3.12 透過G418篩選MLF剔除之梨形鞭毛蟲細胞株之分析 23
3.13 建立梨形鞭毛蟲MLF KO cell line without G418 with HA 篩選透過puromycin 23
3.14 加速去除質體和藥物後之MLF部分剔除細胞株建立 24
3.15 加速去除質體和藥物後之MLF部分剔除細胞株之建立 24
3.16 持續表現質體MLF部分剔除細胞株之建立 25
3.17 持續表現質體MLF部分剔除細胞株之表現 25
3.18 去除質體和藥物後持續表現質體MLF部分剔除細胞株之表現 26
3.19 利用轉染更多的Cas9提升MLF剔除效率 26
3.20針對梨形鞭毛蟲HTH domain基因之 CRISPR/Cas9系統之設計 27
3.21建立HTH domain基因剔除之梨形鞭毛蟲細胞株 27
3.22確定HTH domain 部分剔除之梨形鞭毛蟲細胞株建立 28
3.23梨形鞭毛蟲HTH domain 部分剔除的細胞株的表現 28
3.24去除質體和藥物後之HTH domain 部分剔除細胞株建立 29
3.25去除質體和藥物後之HTH domain 部分剔除細胞株的表現 29
第四章 討論(Discussion) 31
4.1梨形鞭毛蟲的CRISPR/Cas9系統建立 31
4.2透過基因比對人類和梨形鞭毛蟲的連接酶IV 31
4.3運用不同的CRISPR/Cas9系統建立 31
4.4透過CRISPR/Cas9系統建立想運用在GS細胞株 32
REFERENCES 106
dc.language.isozh-TW
dc.title建立梨形鞭毛蟲的CRISPR/Cas9系統zh_TW
dc.titleDevelopment of a CRISPR/Cas9 System in Giardia lamblia.en
dc.typeThesis
dc.date.schoolyear105-2
dc.description.degree碩士
dc.contributor.oralexamcommittee李財坤,許弘明
dc.subject.keyword梨形鞭毛蟲,CRISPR/Cas9,NHEJ,HDR,zh_TW
dc.subject.keywordGiardia lamblia,CRISPR/Cas9,NHEJ,HDR,en
dc.relation.page109
dc.identifier.doi10.6342/NTU201703563
dc.rights.note未授權
dc.date.accepted2017-08-16
dc.contributor.author-college醫學院zh_TW
dc.contributor.author-dept微生物學研究所zh_TW
顯示於系所單位:微生物學科所

文件中的檔案:
檔案 大小格式 
ntu-106-1.pdf
  未授權公開取用
12.21 MBAdobe PDF
顯示文件簡單紀錄


系統中的文件,除了特別指名其著作權條款之外,均受到著作權保護,並且保留所有的權利。

社群連結
聯絡資訊
10617臺北市大安區羅斯福路四段1號
No.1 Sec.4, Roosevelt Rd., Taipei, Taiwan, R.O.C. 106
Tel: (02)33662353
Email: ntuetds@ntu.edu.tw
意見箱
相關連結
館藏目錄
國內圖書館整合查詢 MetaCat
臺大學術典藏 NTU Scholars
臺大圖書館數位典藏館
本站聲明
© NTU Library All Rights Reserved